DK0613499T4 - Humane IT-4-mutantproteiner - Google Patents

Humane IT-4-mutantproteiner

Info

Publication number
DK0613499T4
DK0613499T4 DK92923502T DK92923502T DK0613499T4 DK 0613499 T4 DK0613499 T4 DK 0613499T4 DK 92923502 T DK92923502 T DK 92923502T DK 92923502 T DK92923502 T DK 92923502T DK 0613499 T4 DK0613499 T4 DK 0613499T4
Authority
DK
Denmark
Prior art keywords
pct
date
human
mutant proteins
antagonists
Prior art date
Application number
DK92923502T
Other languages
Danish (da)
English (en)
Other versions
DK0613499T3 (da
Inventor
Walter Prof Dr Sebald
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6444719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0613499(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0613499T3 publication Critical patent/DK0613499T3/da
Publication of DK0613499T4 publication Critical patent/DK0613499T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92923502T 1991-11-13 1992-11-13 Humane IT-4-mutantproteiner DK0613499T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4137333A DE4137333A1 (de) 1991-11-13 1991-11-13 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
PCT/EP1992/002614 WO1993010235A1 (fr) 1991-11-13 1992-11-13 Proteines mutantes de l'il-4 humaine mutante

Publications (2)

Publication Number Publication Date
DK0613499T3 DK0613499T3 (da) 1998-09-23
DK0613499T4 true DK0613499T4 (da) 2005-04-18

Family

ID=6444719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92923502T DK0613499T4 (da) 1991-11-13 1992-11-13 Humane IT-4-mutantproteiner

Country Status (16)

Country Link
US (1) US5723118A (fr)
EP (1) EP0613499B2 (fr)
JP (2) JP3470970B2 (fr)
KR (1) KR100276410B1 (fr)
AT (1) ATE163196T1 (fr)
AU (1) AU671960B2 (fr)
CA (1) CA2123315C (fr)
CZ (1) CZ283467B6 (fr)
DE (2) DE4137333A1 (fr)
DK (1) DK0613499T4 (fr)
ES (1) ES2112340T5 (fr)
GR (1) GR3026600T3 (fr)
HU (1) HU217326B (fr)
NO (1) NO312707B1 (fr)
SK (1) SK280114B6 (fr)
WO (1) WO1993010235A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4423131A1 (de) * 1994-07-01 1996-01-04 Bayer Ag Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4
GB9415379D0 (en) * 1994-07-29 1994-09-21 Smithkline Beecham Plc Novel compounds
CN1117155C (zh) * 1994-07-29 2003-08-06 史密丝克莱恩比彻姆有限公司 新型化合物
ATE272118T1 (de) * 1996-06-14 2004-08-15 Bayer Ag T-zell selektive interleukin-4 agoniste
US5986059A (en) * 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
MY124565A (en) * 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins
US6180108B1 (en) * 1998-12-10 2001-01-30 Bayer Corporation Vectors having terminal repeat sequence of Epstein-Barr virus
DE10022258A1 (de) 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
DK2990420T3 (en) 2000-05-26 2017-04-03 Immunex Corp USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
EP1314739A1 (fr) * 2001-11-22 2003-05-28 Bayer Ag Procédé de renaturation de protéines recombinantes renfermant des liasons disulfure, à des concentrations élevées de protéines en présence d'amines
EP1382614A1 (fr) * 2002-07-15 2004-01-21 Bayer HealthCare AG Procédé de purification de l'interleukine-4 et ses muteines
US7635754B2 (en) * 2004-09-22 2009-12-22 Aerovance, Inc. Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
US20070009479A1 (en) * 2005-06-17 2007-01-11 Aerovance, Inc. Methods for treating dermatitis using mutant human IL-4 compositions
ATE520032T1 (de) * 2006-06-21 2011-08-15 Apogenix Gmbh Differentielle cytokinexpression bei einer menschlichen krebserkrankung
CA2656135A1 (fr) * 2006-07-06 2008-01-10 Apogenix Gmbh Muteines humaines il-4 pour cancerotherapie
EP2596802A1 (fr) 2011-11-23 2013-05-29 PLS-Design GmbH Composition pharmaceutique pour le traitement des réactions allergiques
EP2674168A1 (fr) 2012-06-14 2013-12-18 PLS-Design GmbH Modulation des réponses des lymphocytes T d'effecteur par déplétion locale du composant complément C3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
JPH03500050A (ja) * 1988-02-02 1991-01-10 シェリング・バイオテック・コーポレーション 免疫グロブリンｅの応答を減少させる方法
US5188827A (en) * 1989-12-18 1993-02-23 Schering Corporation Use of interleukin-4- for lowering blood-cholesterol levels

Also Published As

Publication number Publication date
CA2123315A1 (fr) 1993-05-27
EP0613499A1 (fr) 1994-09-07
CA2123315C (fr) 2003-06-17
HUT66826A (en) 1995-01-30
NO941681L (no) 1994-05-06
WO1993010235A1 (fr) 1993-05-27
HU9401369D0 (en) 1994-08-29
EP0613499B2 (fr) 2005-03-30
GR3026600T3 (en) 1998-07-31
JP2003174894A (ja) 2003-06-24
DK0613499T3 (da) 1998-09-23
US5723118A (en) 1998-03-03
DE4137333A1 (de) 1993-05-19
SK55494A3 (en) 1994-12-07
DE59209196D1 (de) 1998-03-19
AU2928292A (en) 1993-06-15
ES2112340T5 (es) 2005-10-16
CZ283467B6 (cs) 1998-04-15
NO941681D0 (no) 1994-05-06
CZ118594A3 (en) 1994-12-15
JP3470970B2 (ja) 2003-11-25
ATE163196T1 (de) 1998-02-15
SK280114B6 (sk) 1999-08-06
KR100276410B1 (ko) 2000-12-15
JPH07501522A (ja) 1995-02-16
AU671960B2 (en) 1996-09-19
EP0613499B1 (fr) 1998-02-11
ES2112340T3 (es) 1998-04-01
NO312707B1 (no) 2002-06-24
HU217326B (hu) 1999-12-28

Similar Documents

Publication Publication Date Title
DK0613499T4 (da) Humane IT-4-mutantproteiner
NO965621L (no) Nye hIL-4-mutantproteiner som antagonister eller partielle agonister for det humane interleukin 4
DE69324671D1 (de) Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute
YU81091A (sh) Analozi 5-(1-hidroksi-2-piperidinopropil)-2-(1h,3h)-indolona
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DK0609280T3 (da) Humane IL-3 varianter
DE69226649D1 (de) Analoge des menschlichen Interleukin-8.
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
ES2084149T3 (es) Conjugados de hirudinpolialquilenglicol.
ATE204021T1 (de) Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase
BR9706891A (pt) Composto, medicamento, composição farmacêutica e composição cosmética.
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
DE69816808D1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
FI952855A (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö
GB9723630D0 (en) M.vaccae preparation and its use
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone